Zimbabwe study targets cancer prevention with vaccines and mental health care
NCT ID NCT06786429
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study in Zimbabwe will screen women of childbearing age and high school students for HPV and Hepatitis B, then offer vaccines to those who are eligible. It also includes cognitive behavioral therapy for mental health issues. The goal is to see if this combined approach can prevent cervical and liver cancers in these groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gardasil 9 vaccine, Hepatitis B Virus Vaccine (HBV), Cognitive Behavioral Therapy
- What this could lead to
- If successful, this approach could reduce cervical and liver cancer rates in Zimbabwe by combining vaccination, screening, and mental health support.
- What could go wrong
- This is an observational study with a large sample, but it does not test a new treatment. Results may not apply to other regions, and vaccine uptake or follow-up may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers